AngioDynamics, Inc. Proceeds from Divestiture of Businesses
AngioDynamics, Inc. (ANGO) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2026-07-14
- AngioDynamics, Inc. proceeds from divestiture of businesses for fiscal 2026 was $0.00.
- AngioDynamics, Inc. proceeds from divestiture of businesses for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- AngioDynamics, Inc. proceeds from divestiture of businesses for fiscal 2024 was $134.50M.
- AngioDynamics, Inc. proceeds from divestiture of businesses for fiscal 2023 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 12 month |
|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-07-14 |
| 2025-05-31 | $0.00 10-K · filed 2026-07-14 |
| 2024-05-31 | $134.50M 10-K · filed 2026-07-14 |
| 2023-05-31 | $0.00 10-K · filed 2025-07-18 |
| 2022-05-31 | $0.00 10-K · filed 2024-07-25 |
| 2021-05-31 | $0.00 10-K · filed 2021-07-27 |
| 2020-05-31 | $0.00 10-K · filed 2021-07-27 |
| 2019-05-31 | $169.24M 10-K · filed 2021-07-27 |
| 2018-05-31 | $0.00 10-K · filed 2020-08-10 |
| 2017-05-31 | $0.00 10-K · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |